NASDAQ: UTHR
United Therapeutics Corp Stock Ownership - Who owns United Therapeutics?

Insider buying vs selling

Have United Therapeutics Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Martine A. RothblattCEO;Chair2026-08-13640$508.76
$325.61kSell
Martine A. RothblattCEO;Chair2026-08-13200$509.92
$101.98kSell
Martine A. RothblattCEO;Chair2026-08-13160$511.12
$81.78kSell
Martine A. RothblattCEO;Chair2026-08-13240$512.36
$122.97kSell
Martine A. RothblattCEO;Chair2026-08-139,500$135.42
$1.29MBuy
Martine A. RothblattCEO;Chair2026-08-131,253$500.08
$626.60kSell
Martine A. RothblattCEO;Chair2026-08-131,328$500.93
$665.24kSell
Martine A. RothblattCEO;Chair2026-08-131,519$501.88
$762.35kSell
Martine A. RothblattCEO;Chair2026-08-13440$502.93
$221.29kSell
Martine A. RothblattCEO;Chair2026-08-13160$503.83
$80.61kSell

1 of 270

UTHR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when UTHR insiders and whales buy or sell their stock.

UTHR Shareholders

What type of owners hold United Therapeutics Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Lilly Co Eli2.14%5,251,394$2.62BInsider
Martine A. Rothblatt0.36%885,463$442.49MInsider
Swedbank Ab0.13%322,995$161.41MInstitution
Assenagon Asset Management Sa0.03%84,538$42.25MInstitution
Atwood Palmer Inc0.03%61,479$30.72MInstitution
Simplify Asset Management Inc0.02%45,411$22.69MInstitution
Paul A. Mahon0.02%45,172$22.57MInsider
Tommy G. Thompson0.01%36,480$18.23MInsider
Ardsley Advisory Partners LP0.01%30,000$14.99MInstitution
Nepsis Inc0.01%27,273$13.63MInstitution

1 of 3

UTHR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
UTHR0.02%2.59%Net SellingNet Buying
VRTX0.09%1.52%Net SellingNet Selling
REGN0.09%39.26%Net SellingNet Selling
ARGX0.05%0.00%
RVMD0.10%9.05%Net SellingNet Selling

United Therapeutics Stock Ownership FAQ

Who owns United Therapeutics?

United Therapeutics (NASDAQ: UTHR) is owned by 0.02% institutional shareholders, 2.59% United Therapeutics insiders, and 97.39% retail investors. Lilly Co Eli is the largest individual United Therapeutics shareholder, owning 5.25M shares representing 2.14% of the company. Lilly Co Eli's United Therapeutics shares are currently valued at $2.62B.

If you're new to stock investing, here's how to buy United Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.